Table 1.

RBC parameter values for different mouse strains and treatments used in the study

Mouse strainRBC (106/μL)Hb
(g/dL)
HCT%MCV (fL)MCH (pg)MCHC (g/dL)RDW-CV %RET count (103/μL)RET%
WT transplanted (HSC-WT → WT recipients) n = 7 9.1
± 0.2  
13.1
± 0.3  
43.2
± 1.0,  
47.7
± 0.9,,  
14.4
± 0.2,,  
30.2
± 0.4  
14.8
± 0.3,,  
443.1
± 40.4  
4.8
± 0.4,  
Hba-a1Fl/Fl/Hba-a2KO/KO, n = 15 10.9
± 0.1§  
14.3
± 0.3§  
46.85
± 0.9§  
43.2
± 0.8 
13.1
± 0.2 
30.5
± 0.2 
19.9
± 0.8§  
505.2
± 25.5 
4.7
± 0.2§  
Hba-a1KO/+/Hba-a2KO/+, n = 9 9.0
± 0.4§  
11.4
± 0.5§  
35.99
± 1.6,§  
40.2
± 1.1  
12.8
± 0.2  
31.8
± 0.5 
31.0
± 1.2,§,||  
605.0
± 37.4 
6.8
± 0.5,§  
HSC Hba-a1Fl/Fl/Hba-a2KO/KO + mRNACre-LNPCD117
(Hba-a1cKO/cKO/Hba-a2KO/KO) → WT recipients (AG-KO), n = 8 
13.0
± 0.4,  
14.7
± 0.3,  
68.2
± 1.3,  
52.8
± 1.4,  
11.4
± 0.3,#  
21.6
± 0.2,  
39.0
± 0.7,  
2796.2
± 114.6,  
21.7
± 1.0,  
FLC Hba-a1KO/KO/Hba-a2KO/KO → WT recipients (AG-FKO), n = 5 12.6
± 0.6 
15.9
± 0.7 
75.34
± 4.1 
60.0
± 2.6 
12.6
± 0.2# 
21.1
± 0.6 
43.7
± 1.4 
2620.9
± 160.7 
21.0
± 1.5 
HSC Hba-a1Fl/Fl/Hba-a2KO/KO + mRNACre-LNPCD117 + ALS20αI (Hba-a1cKO/cKO/Hba-a2KO/KO + ALS20αI) → WT recipients (AG-KOALS20αI), n = 7 10.0
± 0.5  
12.0
± 0.4  
38.6
± 1.6  
38.7
± 0.6,  
12.1
± 0.2  
31.2
± 0.5  
24.4
± 0.7,||,  
745.9
± 76.5,  
7.4
± 0.1,  
Mouse strainRBC (106/μL)Hb
(g/dL)
HCT%MCV (fL)MCH (pg)MCHC (g/dL)RDW-CV %RET count (103/μL)RET%
WT transplanted (HSC-WT → WT recipients) n = 7 9.1
± 0.2  
13.1
± 0.3  
43.2
± 1.0,  
47.7
± 0.9,,  
14.4
± 0.2,,  
30.2
± 0.4  
14.8
± 0.3,,  
443.1
± 40.4  
4.8
± 0.4,  
Hba-a1Fl/Fl/Hba-a2KO/KO, n = 15 10.9
± 0.1§  
14.3
± 0.3§  
46.85
± 0.9§  
43.2
± 0.8 
13.1
± 0.2 
30.5
± 0.2 
19.9
± 0.8§  
505.2
± 25.5 
4.7
± 0.2§  
Hba-a1KO/+/Hba-a2KO/+, n = 9 9.0
± 0.4§  
11.4
± 0.5§  
35.99
± 1.6,§  
40.2
± 1.1  
12.8
± 0.2  
31.8
± 0.5 
31.0
± 1.2,§,||  
605.0
± 37.4 
6.8
± 0.5,§  
HSC Hba-a1Fl/Fl/Hba-a2KO/KO + mRNACre-LNPCD117
(Hba-a1cKO/cKO/Hba-a2KO/KO) → WT recipients (AG-KO), n = 8 
13.0
± 0.4,  
14.7
± 0.3,  
68.2
± 1.3,  
52.8
± 1.4,  
11.4
± 0.3,#  
21.6
± 0.2,  
39.0
± 0.7,  
2796.2
± 114.6,  
21.7
± 1.0,  
FLC Hba-a1KO/KO/Hba-a2KO/KO → WT recipients (AG-FKO), n = 5 12.6
± 0.6 
15.9
± 0.7 
75.34
± 4.1 
60.0
± 2.6 
12.6
± 0.2# 
21.1
± 0.6 
43.7
± 1.4 
2620.9
± 160.7 
21.0
± 1.5 
HSC Hba-a1Fl/Fl/Hba-a2KO/KO + mRNACre-LNPCD117 + ALS20αI (Hba-a1cKO/cKO/Hba-a2KO/KO + ALS20αI) → WT recipients (AG-KOALS20αI), n = 7 10.0
± 0.5  
12.0
± 0.4  
38.6
± 1.6  
38.7
± 0.6,  
12.1
± 0.2  
31.2
± 0.5  
24.4
± 0.7,||,  
745.9
± 76.5,  
7.4
± 0.1,  

Mean values are listed with the standard error of the mean. Symbols by values indicate significance (P ≤ .5) between 2 cohorts for that parameter, with comparisons made as indicated in the table legend. Significant differences were determined using a Brown-Forsythe and Welch analysis of variance with Dunnett T3 multiple comparisons test. Male and female AG-KOALS20αI mice were compared for each parameter, and no significant differences were found. Statistical analyses were then performed on samples pooled from male and female animals. “→” indicates HSC transplants using cells from the donor mice into recipient mice. Differences between the heterozygous Hba-a1KO/+/Hba-a2KO/+ constitutive KO animals and homozygous Hba-a1cKO/cKO/Hba-a2KO/KO are likely due to differential levels of α-globin expression from different α-globin genes, a known effect in humans. HBA2 and its ortholog Hba-a1 are expressed at higher levels than HBA1 and Hba-a2.39-41Hba-a1 is analogous to HBA2 in humans, which is 5′ of HBA1, and appears to be dominantly expressed. Therefore, because Hba-a1KO/+/Hba-a2KO/+ mice are missing 1 Hba-a1 and 1 Hba-a2, it is reasonable to predict that they would have a more severe phenotype than Hba-a1cKO/cKO/Hba-a2KO/KO mice that are missing 2 Hba-a2 genes.

Hb, hemoglobin; HCT, hematocrit; MCH, mean corpuscular Hb; MCHC, mean corpuscular Hb concentration; MCV, mean corpuscular volume; RBC, red blood cells; RDW-CV, coefficient of variation in red cell distribution width; RET, reticulocyte; RET%, percentage of reticulocytes.

Comparison between groups 1 and 4 (WT and AG-KO)

Comparison between groups 1 and 3 (WT and Hba-a1ko/+/Hba-a2ko/+)

Comparison between groups 6 and 1 (AG-KOALS20αI and WT)

§

Comparison between groups 2 and 3 (Hba-a1Fl/Fl/Hba-a2ko/KO and Hba-a1ko/+/Hba-a2ko/+)

||

Comparison between groups 6 and 3 (AG-KOALS20αI and Hba-a1ko/+/Hba-a2ko/+)

Comparison between groups 6 and 4 (AG-KOALS20αI and AG-KO)

#

Comparison between groups 4 and 5 (AG-KO and AG-FKO), no differences were observed.

or Create an Account

Close Modal
Close Modal